抗菌药物管理项目对约旦医院广谱抗生素使用及碳青霉烯耐药鲍曼不动杆菌的影响
该研究为约旦某三级教学医院6年回顾性生态学评估,2018年2月实施包含教育、指南、限制性审批与反馈的抗菌药物管理项目。时间序列分析显示,项目实施后亚胺培南/西司他丁、所有碳青霉烯类、万古霉素、黏菌素和第三代头孢菌素使用水平显著下降,碳青霉烯耐药鲍曼不动杆菌水平也显著降低。
要点
- 抗菌药物管理项目可显著降低多种广谱抗生素的使用水平。
- 项目实施与碳青霉烯耐药鲍曼不动杆菌水平显著降低相关。
- 限制性审批与反馈相结合的综合干预可扭转部分抗生素使用趋势。
核心结论
- 引入的抗菌药物管理干预减少了多种广谱抗生素的使用,扭转了其他抗生素使用增加的趋势,并与碳青霉烯耐药鲍曼不动杆菌显著减少相关。
研究设计与样本
- 干预为2018年2月实施的抗菌药物管理项目,包含教育、抗生素指南、需预先审批的抗生素限制政策、限制政策依从性审计与反馈。
- 限制性抗生素包括亚胺培南/西司他丁、厄他培南、美罗培南、万古霉素、替考拉宁、替加环素、黏菌素、阿米卡星、哌拉西林/他唑巴坦、左氧氟沙星和环丙沙星。
- 采用时间序列方法评价干预效果。
主要发现
- 引入抗菌药物管理项目后,亚胺培南/西司他丁使用水平显著下降(P = 0.0008)。
- 所有碳青霉烯类使用水平显著下降(P = 0.0001)。
- 万古霉素使用水平显著下降(P = 0.0006),黏菌素使用水平显著下降(P = 0.0016),第三代头孢菌素使用水平显著下降(P = 0.0004)。
- 引入抗菌药物管理项目后,厄他培南(P = 0.0044)和环丙沙星(P = 0.0117)的使用斜率显著下降。
- 哌拉西林/他唑巴坦在引入前呈显著上升趋势(P = 0.0208),引入后该上升趋势停止(P = 0.4574);引入抗菌药物管理项目与碳青霉烯耐药鲍曼不动杆菌水平降低显著相关(P = 0.0237)。
临床怎么用
- 在三级教学医院可实施包含教育、指南、限制性审批、依从性审计与反馈的综合抗菌药物管理项目以降低广谱抗生素使用。
- 该综合干预模式可作为减少碳青霉烯耐药鲍曼不动杆菌的潜在策略之一。
局限性
- 研究为单中心回顾性生态学评估,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the impact of an antimicrobial stewardship programme (ASP) on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistant Acinetobacter baumannii (CRAb) in hospitalized patients. METHODS: The study was a retrospective, ecological assessment in a tertiary teaching hospital over 6 years (January 2014 to December 2019). The intervention involved the implementation of an ASP in February 2018, which remains in effect today. This ASP consists of several components, including education, antibiotic guidelines, antibiotic restriction policy with prior approval, audit of compliance to the restriction policy and feedback. Restricted antibiotics were imipenem/cilastatin, ertapenem, meropenem, vancomycin, teicoplanin, tigecycline, colistin, amikacin, piperacillin/tazobactam, levofloxacin and ciprofloxacin. The intervention was evaluated by time-series methods. RESULTS: Statistically significant decreases in the level of antibiotic use, after the introduction of the ASP, were observed for the following antibiotics: imipenem/cilastatin (P = 0.0008), all carbapenems (P = 0.0001), vancomycin (P = 0.0006), colistin (P = 0.0016) and third-generation cephalosporins (P = 0.0004). A statistically significant decrease in the slope, after the introduction of the ASP, for ertapenem (P = 0.0044) and ciprofloxacin (P = 0.0117) was observed. For piperacillin/tazobactam, there was a significant increasing trend (P = 0.0208) before the introduction of the ASP. However, this increased trend was halted post-introduction of the ASP (P = 0.4574). The introduction of the ASP was associated with a significant impact on reducing the levels of CRAb (P = 0.0237). CONCLUSIONS: The introduced antimicrobial stewardship interventions contributed to a reduction in the use of several broad-spectrum antibiotics, reversed the trends of increasing use of other antibiotics and were associated with a significant reduction in CRAb.
引用
- Yusef D, Hayajneh WA, Bani Issa A, et al. Impact of an antimicrobial stewardship programme on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistant Acinetobacter baumannii (CRAb) in hospitals in Jordan. J Antimicrob Chemother. 2021. PMID: 33219679. doi:10.1093/jac/dkaa464
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。